Human liver allograft acceptance and the "tolerance assay" II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH

Human Immunology

Volumn 63, Issue 10, 2002, Pages 862-870

  Jankowska Gan, Ewa ^a,d   Rhein, Tonja ^b   Haynes, Lynn D ^a   Geissler, Felix ^b   Mulder, Arend ^c   Kalayoglu, Munci ^a   Sollinger, Hans ^a   Burlingham, William J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d H4/781 CSC ^*  (United States)

Author keywords

DTH; Linked suppression

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; TETANUS TOXOID;

ALLOGRAFT; ANIMAL MODEL; ARTICLE; ASSAY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DONOR; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIVER GRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; LIVER TRANSPLANTATION; MICE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036774327     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00450-0     Document Type: Article

References (28)

1. Shevach EM: Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423, 2000.
2. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest 106:145, 2000.
3. Geissler F, Jankowska-Gan E, DeVito-Haynes LD, Rhein T, Kalayoglu M, Sollinger HW, Burlingham WJ: Human liver allograft acceptance and the "tolerance assay:" In vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression. Transplantation 72:571, 2001.
4. Zachary AA, Teresi GA: Laboratory Manual. New York: American Society for Histocompatibility and Immunogenetics, 1990.
5. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992.
6. Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S: Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation 45:632, 1988.
7. El-Zaatari FAK, Taurog JD: In vitro mutagenesis of HLA-B27: Single and multiple amino acid substitutions at consensus B27 sites identify distinct monoclonal antibody-defined epitopes. Hum Immunol 33:243, 1992.
8. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970.
9. DeVito LD, Sollinger HW, Burlingham WJ: Adsorption of cytotoxic anti-HLA antibodies with HLA class I immunosorbant beads. Transplantation 49:925, 1990.
10. Shimizu Y, DeMars R: Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J Immunol 142:3320, 1989.
11. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R: Transfer and expression of three cloned human non-A, -B, -C class I histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 85:227, 1988.
12. DeMars R, Chang CC, Shaw S, Reitnauer PJ, Sondel PM: Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol 11:77, 1984.
13. Parham P: Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns. J Biol Chem 254:8709, 1979.
14. DeVito-Haynes LD, Jankowska-Gan E, Heisey DM, Cornwell RD, Meyer KC, Love RB, Burlingham WJ: Soluble HLA class I in epithelial lining fluid of lung transplants: Associations with graft outcome. Hum Immunol 52:95, 1997.
15. Tanabe M, Sekimata M, Ferrone S, Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reactive with the HLA class I a3 domain. J Immunol 148:3202, 1992.
16. Hiraki DD, See-Tho K, Filvaroff E, Krishnaswamy S, de Bello W, Taidi-Laskowski B, Grumet FC: Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization. Hum Immunol 40:235, 1994.
17. Carrodeguas L, Orosz CG, Waldman WJ, Sedmak DD, Adams PW, VanBuskirk AM: Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol 60:640, 1999.
18. Gould DS, Auchincloss Jr H: Direct and indirect recognition: The role of MHC antigens in graft rejection. Immunol Today 20:77, 1999.
19. Smith FI, Miller JFAP: Delayed type hypersensitivity to allogeneic cells in mice. III. Sensitivity to cell-surface antigens coded by the major histocompatibility complex and other genes. J Exp Med 150:965, 1979.
20. Burlingham WJ, Jankowska-Gan E, VanBuskirk A, Orosz CG, Lee JH, Kusaka S: Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis. Hum Immunol 61:1395, 2000.
21. Watschinger B, Gallon L, Carpenter CB, Sayegh M: Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 57:572, 1994.
22. SivaSai KS, Smith MA, Poindexter NJ, Sundaresan S, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T: Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 67:1094, 1999.
23. Lee J, Jankowska-Gan E, Kratachwill TT, Kusaka S, Van-Buskirk AM, Burlingham WJ. Human CD4+CD25 low T regulatory cells specific for donor-derived HLA-B allopeptide mediate CTLA-4 and TOF-B1-dependent inhibition of delayed-type hypersensitivity during allograft acceptance [Abstract]. Am J Transplant 2 (Suppl 3):213, 2002.
24. Davies HffS, Pollard SG, Calne RY: Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47:524, 1989.
25. DeVito-Haynes LD, Jankowska-Gan E, Meyer KC, Cornwell RD, Zeevi A, Griffith B, Dauber J, Iacono A, Burlingham WJ, Love RB: Soluble donor HLA class I and b2m-free heavy chain in serum of lung transplant recipients: Steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. Hum Immunol 61:1370, 2000.
26. Burlingham WJ, Torrealba J, Schultz J, Katayama M, Kusaka S, Jankowska-Gan E, Fechner JH, Oberly T, Hamawy MM, Knechtle SJ: Distinct transforming growth factor beta (TGFB) staining patterns of transplant acceptance vs. rejection in Rhesus monkey renal allografts: correlation with DTH regulation status [Abstract]. Am J Transplant 2 (Suppl 3):143, 2002.
27. Burlingham WJ, Jankowska-Gan E, VanBuskirk AM, Orosz CG, Fechner JH, Hamawy M, Knechtle SJ: Immunogregulation in monkey kidney allograft acceptance: Bystander suppression of DTH triggered by donor antigens. Transplantation 69:242, 2000.
28. Sonntag KC, Emery DW, Yasumoto A, Haller G, Germana S, Sablinski T, Shimizu A, Yamada K, Shimada H, Arn S, Sachs DH, LeGuern C: Tolerance to solid organ transplants through transfer of MHC class II genes. J Clin Invest 107:65, 2001.